TROP2 NMR Concordance Study
← catalyst calendarNCT07624318 · readout in 300 d
Sponsored by AstraZeneca (industry) · AZN — their whole pipeline →.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
3,400estimated
Sites
3
Country
China
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-06-15 | estimated | When the study began enrolling |
| Primary completion | 2027-06-15 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-06-15 | estimated | The whole study's end, after follow-up |
| First posted | 2026-06-03 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-15 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Lung Cancer
Interventions
- Device: Reference solution
- Device: Mixed solution
- Device: Local solution
Primary outcomes
what the primary-completion date above is the date OFStage 1 - Solution concordance in central lab: To evaluate TROP2 NMR concordance between Local solution and Reference solution in the central lab
measured Approximately 6 months after collection of the first slide.
Stage2 - TROP2 NMR testing concordance among labs：To evaluate TROP2 NMR concordance of Reference solution between sites and central lab
measured Approximately 10 months after collection of the first slide.
Stage2 - TROP2 NMR testing concordance among labs：To evaluate TROP2 NMR concordance of Local solution in sites with Reference solution in central lab
measured Approximately 10 months after collection of the first slide.
Permalink · AZN's whole pipeline · Catalyst calendar · Every registered study · What changed